Home NDC 0378-6629 Eprosartan Mesylate
Product NDC 0378-6629
11-digit product format 003786629
Labeler code 0378
Product ID 0378-6629_ab531d28-345b-4113-9fde-00cd63ad5b1a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name eprosartan mesylate
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Mylan Pharmaceuticals Inc.
Application ANDA202012
Marketing category ANDA
Marketing start 2011-12-20
Marketing end 0000-00-00
Substance EPROSARTAN MESYLATE
Active strength 600 mg/1
Pharmacologic classes Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0378-6629-93 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0378-6629-93 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0378-6629-93 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0378-6629-93 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0378-6629-93 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0378-6629-93 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0378-6629-93 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0378-6629-93 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0378-6629-93 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0378-6629-93 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0378-6629-93 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0378-6629-93 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A202012-001 EPROSARTAN MESYLATE EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 A202012-002 EPROSARTAN MESYLATE EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 84e616aacf4f…2026-08-18 06:07:40 2026-07 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL AB 2011-11-16 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL AB RS 2011-11-16 74a2ff9319b5…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded EPROSARTAN MESYLATE ACTIVE INGREDIENT 8N2L1NX8S3 EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 EPROSARTAN ACTIVE MOIETY 2KH13Z0S0Y EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 AMMONIA INACTIVE INGREDIENT 5138Q19F1X EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 POVIDONES INACTIVE INGREDIENT FZ989GH94E EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 SHELLAC INACTIVE INGREDIENT 46N107B71O EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP EPROSARTAN MESYLATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 5